Amgen (AMGN) Non-Current Debt (2016 - 2025)
Historic Non-Current Debt for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $50.0 billion.
- Amgen's Non-Current Debt fell 1157.23% to $50.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $50.0 billion, marking a year-over-year decrease of 1157.23%. This contributed to the annual value of $50.0 billion for FY2025, which is 1157.23% down from last year.
- Per Amgen's latest filing, its Non-Current Debt stood at $50.0 billion for Q4 2025, which was down 1157.23% from $52.4 billion recorded in Q3 2025.
- Over the past 5 years, Amgen's Non-Current Debt peaked at $63.2 billion during Q4 2023, and registered a low of $28.5 billion during Q2 2021.
- Moreover, its 5-year median value for Non-Current Debt was $53.1 billion (2025), whereas its average is $47.8 billion.
- Its Non-Current Debt has fluctuated over the past 5 years, first plummeted by 1662.61% in 2021, then soared by 6911.17% in 2023.
- Amgen's Non-Current Debt (Quarter) stood at $33.2 billion in 2021, then increased by 12.44% to $37.4 billion in 2022, then surged by 69.11% to $63.2 billion in 2023, then decreased by 10.48% to $56.5 billion in 2024, then dropped by 11.57% to $50.0 billion in 2025.
- Its Non-Current Debt stands at $50.0 billion for Q4 2025, versus $52.4 billion for Q3 2025 and $53.8 billion for Q2 2025.